Ian Nicholson is Chair of the Remuneration Committee. Ian has over 35 years’ international experience in management and transactions within the life sciences sector including as chairman of Bioventix plc, as operating partner at London-based Advent Life Sciences LLP, and 8 years as CEO of the privately held anti-fungal drug development company F2G Limited. Ian has worked extensively in licensing, mergers and acquisitions and market development in the UK, Europe and the USA.
![A portrait of Ian Nicholson.](https://www.lifearc.org/wp-content/uploads/2021/10/Ian-Nicholson-1-e1710785829615.png)
Ian Nicholson
Latest news
-
New smartphone app offers hope in the fight against neglected tropical diseases
Read more: New smartphone app offers hope in the fight against neglected tropical diseases -
Bronchiectasis: an overlooked lung condition with untapped commercial and research potential
Read more: Bronchiectasis: an overlooked lung condition with untapped commercial and research potential -
Cambridge Science Centre opens new facility that will educate and inspire the next generation of scientists
Read more: Cambridge Science Centre opens new facility that will educate and inspire the next generation of scientists